M3, Inc. Stock

Equities

2413

JP3435750009

Internet Services

Delayed Japan Exchange 11:34:42 2024-04-23 pm EDT 5-day change 1st Jan Change
1,920 JPY +1.91% Intraday chart for M3, Inc. +1.27% -17.75%
Sales 2024 * 241B 1.56B Sales 2025 * 266B 1.72B Capitalization 1,279B 8.26B
Net income 2024 * 49.26B 318M Net income 2025 * 54.4B 351M EV / Sales 2024 * 4.74 x
Net cash position 2024 * 137B 886M Net cash position 2025 * 161B 1.04B EV / Sales 2025 * 4.2 x
P/E ratio 2024 *
26 x
P/E ratio 2025 *
23.5 x
Employees 10,533
Yield 2024 *
1.1%
Yield 2025 *
1.2%
Free-Float 60.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.86%
1 week+1.27%
Current month-10.20%
1 month-9.07%
3 months-23.45%
6 months-19.15%
Current year-17.75%
More quotes
1 week
1 776.50
Extreme 1776.5
1 926.00
1 month
1 776.50
Extreme 1776.5
2 205.00
Current year
1 776.50
Extreme 1776.5
2 527.50
1 year
1 776.50
Extreme 1776.5
3 429.00
3 years
1 776.50
Extreme 1776.5
8 945.00
5 years
1 776.50
Extreme 1776.5
10 675.00
10 years
641.00
Extreme 641
10 675.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
President 59 00-09-28
Director/Board Member 52 09-12-31
Members of the board TitleAgeSince
President 59 00-09-28
Director/Board Member 65 14-05-31
Director/Board Member 59 09-05-31
More insiders
Date Price Change Volume
24-04-23 1,920 +1.91% 1 265 400
24-04-23 1,884 +1.24% 2,664,400
24-04-22 1,861 +4.00% 3,460,300
24-04-19 1,790 -4.99% 5,649,000
24-04-18 1,884 -0.61% 1,684,800

Delayed Quote Japan Exchange, April 23, 2024 at 11:34 pm EDT

More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows: - medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE; - support services to medical institutions (16.5%): - clinical trial related services (10.7%): clinical trial support and clinical trial operations management services; - human resources services (6.6%); - other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites. The balance of sales (24.3%) concerns international activities.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
1,884 JPY
Average target price
2,565 JPY
Spread / Average Target
+36.15%
Consensus